

[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
Gena Wang Maintained (BMRN) at Buy with Decreased Target to $86 on, Oct 4th, 2024
Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $110 to $86 on, Oct 4th, 2024.
Gena has made no other calls on BMRN in the last 4 months.
There are 12 other peers that have a rating on BMRN. Out of the 12 peers that are also analyzing BMRN, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- George Farmer of "Scotiabank" Maintained at Hold with Decreased Target to $78 on, Tuesday, September 17th, 2024
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
These are the ratings of the 10 analyists that currently disagree with Gena
- Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $115 on, Tuesday, September 17th, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, September 17th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $90 on, Tuesday, September 17th, 2024
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $87 on, Tuesday, September 17th, 2024
- William Pickering of "Bernstein" Maintained at Buy with Decreased Target to $90 on, Tuesday, September 17th, 2024
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
- Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
Contributing Sources